R92.323

Clinical Causes: Genetic factors influencing breast tissue composition Hormonal influences, such as fluctuations in estrogen and progesterone Age-related changes in breast tissue structure Breast density tends to be higher in younger women and decreases with age A personal or family history of certain breast conditions

Key Symptoms: Typically, mammographic fibroglandular density does not cause physical symptoms It may be associated with a feeling of breast firmness or heaviness in some cases Increased breast density can lead to a more complex interpretation of mammograms, potentially affecting breast cancer screening effectiveness

Diagnosis Path: The diagnosis of fibroglandular density is made through mammographic imaging. During a mammogram, radiologists assess the composition of breast tissue and categorize its density. Dense breast tissue appears white on mammograms, contrasting with fatty tissue, which appears dark. The classification may range from low to high density, with the bilateral fibroglandular density indicating significant glandular and fibrous tissue presence in both breasts. No additional tests are typically required unless other suspicious findings are present.

Treatment Protocols: Mammographic fibroglandular density is a normal variation in breast tissue. It does not require medical treatment unless associated with other findings or concern. Patients are usually advised to continue routine screening mammograms as recommended by healthcare providers. If dense tissue complicates the detection of abnormalities, supplemental imaging tests like ultrasound or MRI may be considered for comprehensive assessment.